Tobira Therapeutics, Inc. Increase (Decrease) in Accrued Liabilities
Tobira Therapeutics, Inc. reported Increase (Decrease) in Accrued Liabilities of $1.03 million for the 3-month period ending 2015-03-31, per its 10-Q filed 2015-04-29.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedLiabilities · last filed 2015-04-29
- Tobira Therapeutics, Inc. increase (decrease) in accrued liabilities for the quarter ending 2015-03-31 was $1.03M, a 30.88% decline year-over-year.
- Tobira Therapeutics, Inc. increase (decrease) in accrued liabilities for the quarter ending 2014-12-31 was -$1.96M, a 495.36% decline year-over-year.
- Tobira Therapeutics, Inc. increase (decrease) in accrued liabilities for the quarter ending 2014-09-30 was -$2.67M, a 173.87% decline year-over-year.
- Tobira Therapeutics, Inc. increase (decrease) in accrued liabilities for the quarter ending 2014-06-30 was $3.91M, a 3108.20% increase year-over-year.
- Tobira Therapeutics, Inc. increase (decrease) in accrued liabilities for fiscal 2014 was $774.00K, a 83.66% decline from fiscal 2013.
- Tobira Therapeutics, Inc. increase (decrease) in accrued liabilities for fiscal 2013 was $4.74M.
- Tobira Therapeutics, Inc. increase (decrease) in accrued liabilities for fiscal 2012 was -$525.00K.
| Period end | Increase (Decrease) in Accrued Liabilities 3 month | Increase (Decrease) in Accrued Liabilities 6 month | Increase (Decrease) in Accrued Liabilities 9 month | Increase (Decrease) in Accrued Liabilities 12 month | Increase (Decrease) in Accrued Liabilities 142 month | Increase (Decrease) in Accrued Liabilities 145 month | Increase (Decrease) in Accrued Liabilities 148 month |
|---|---|---|---|---|---|---|---|
| 2015-03-31 | $1.03M 10-Q · filed 2015-04-29 | -$927.00K derived: sum of 2 quarters · filed 2015-04-29 | -$3.60M derived: sum of 3 quarters · filed 2015-04-29 | $312.00K derived: sum of 4 quarters · filed 2015-04-29 | |||
| 2014-12-31 | -$1.96M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-12 | -$4.64M derived: sum of 2 quarters · filed 2015-02-12 | -$722.00K derived: sum of 3 quarters · filed 2015-02-12 | $774.00K 10-K · filed 2015-02-12 | |||
| 2014-09-30 | -$2.67M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-06 | $1.24M derived: sum of 2 quarters · filed 2014-11-06 | $2.73M 10-Q · filed 2014-11-06 | $3.23M derived: sum of 4 quarters · filed 2015-04-29 | |||
| 2014-06-30 | $3.91M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-11 | $5.41M 10-Q · filed 2014-08-11 | $5.91M derived: sum of 3 quarters · filed 2015-04-29 | $9.53M derived: sum of 4 quarters · filed 2015-04-29 | |||
| 2014-03-31 | $1.50M 10-Q · filed 2015-04-29 | $1.99M derived: sum of 2 quarters · filed 2015-04-29 | $5.61M derived: sum of 3 quarters · filed 2015-04-29 | $5.74M derived: sum of 4 quarters · filed 2015-04-29 | $7.02M 10-Q · filed 2014-05-13 | ||
| 2013-12-31 | $496.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-12 | $4.12M derived: sum of 2 quarters · filed 2015-02-12 | $4.24M derived: sum of 3 quarters · filed 2015-02-12 | $4.74M 10-K · filed 2015-02-12 | $5.86M 10-K · filed 2014-03-12 | ||
| 2013-09-30 | $3.62M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-06 | $3.74M derived: sum of 2 quarters · filed 2014-11-06 | $4.24M 10-Q · filed 2014-11-06 | $2.93M derived: sum of 4 quarters · filed 2014-11-06 | $4.96M 10-Q · filed 2013-11-08 | ||
| 2013-06-30 | $122.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-11 | $621.00K 10-Q · filed 2014-08-11 | -$690.00K derived: sum of 3 quarters · filed 2014-08-11 | ||||
| 2013-03-31 | $499.00K 10-Q · filed 2014-05-13 | -$812.00K derived: sum of 2 quarters · filed 2014-05-13 | |||||
| 2012-12-31 | -$1.31M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-12 | -$525.00K 10-K · filed 2014-03-12 | |||||
| 2012-09-30 | $786.00K 10-Q · filed 2013-11-08 |